NCT01093105
Withdrawn
N/A
A Multicenter, Prospective, Longitudinal, Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (Krabbe Disease)
ConditionsLeukodystrophy, Globoid Cell
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Leukodystrophy, Globoid Cell
- Sponsor
- Shire
- Primary Endpoint
- To measure the change from baseline in growth parameters (eg, weight gain, linear growth, head circumference).
- Status
- Withdrawn
- Last Updated
- 4 years ago
Overview
Brief Summary
The objective of this study is to evaluate the natural history of disease progression in infants with globoid cell leukodystrophy (GLD).
Detailed Description
This study is being conducted to gather prospective data on disease progression in infants diagnosed with GLD. This study will be performed using protocol-defined, standardized assessments including clinical, developmental, and neurologic measures. All study visits will be conducted in the subject's home. No travel to the study site is necessary.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects must meet all of the following criteria to be considered eligible for this study:
- •The subject has a documented diagnosis of GLD as evidenced by GALC enzyme activity or a GALC genotype that is predictive of GLD.
- •The subject must have clinical signs and symptoms consistent with the diagnosis of infantile GLD including at least 2 of the following:
- •Chronic difficulty with feeding or unexplained irritability or "fisting" or other signs of abnormal increased tone
- •CT or MRI imaging, if performed during diagnostic evaluation prior to enrollment, consistent with GLD
- •Failure to meet at least 2 age-specific developmental milestones consistent with GLD
- •Loss of deep tendon reflexes or abnormal visual fixation or optic atrophy
- •The subject has documented onset of signs and symptoms consistent with GLD at \<12 months of age and is \<21 months of age at time of study entry.
- •The subject was born at a gestational age of 35-41 weeks.
- •The subject had a birth weight of ≥2 kg.
Exclusion Criteria
- •Subjects who meet any of the following criteria are not eligible for this study:
- •The subject has neurologic, hearing or vision impairment, difficulty swallowing or feeding, respiratory complications, behavioral disturbances, or other medical conditions that are not due to GLD and are likely to confound the scientific integrity or interpretation of study assessments, as determined by the Investigator.
- •The subject has received treatment with any investigational drug or a device within the 30 days prior to study enrollment through study completion.
- •The subject has received a cord blood or bone marrow transplant or is planning to receive one during the study.
- •The subject's parent(s) or legal guardian is unable to understand the nature, scope, and possible consequences of the study, or does not agree to comply with the protocol defined schedule of assessments.
Outcomes
Primary Outcomes
To measure the change from baseline in growth parameters (eg, weight gain, linear growth, head circumference).
Time Frame: 1 year
To determine the onset date of inadequate oral nutrition, hydration, and/or ventilation as a biomarker for survival
Time Frame: 1 year
Secondary Outcomes
- To assess the change from baseline in clinical parameters of GLD disease progression from a standardized infant neurological examination and infant distress scales.(1 year)
- To assess the AE experience in this patient population(1 year)
- To assess the change from baseline in clinical parameters described in Hagberg's clinical staging.(1 year)
- To measure the time to absolute survival(1 year)
Similar Trials
Completed
N/A
A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)Hypophosphatasia (HPP)NCT01419028Alexion Pharmaceuticals, Inc.48
Active, Not Recruiting
N/A
Early Neurological Outcome in Newborns With Mild Encephalopathy:a Regional NetworkHypoxic EncephalopathyNCT05785481Fondazione Policlinico Universitario Agostino Gemelli IRCCS27
Completed
N/A
Prospective Research in Infants With Mild EncephalopathyHypoxic-Ischemic EncephalopathyBrain InjuryNeonatal SeizureNCT01747863McGill University Health Centre/Research Institute of the McGill University Health Centre63
Completed
N/A
National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.CytopeniaAutoimmune Haemolytic AnaemiaThrombocytopenic Purpura, ImmuneNCT04070612University Hospital, Bordeaux122
Active, Not Recruiting
N/A
Observational Evaluation of Atopic Dermatitis in Pediatric PatientsDermatitis AtopicNCT03687359Sanofi1,860